|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||280.60 - 284.05|
|52 Week Range||244.28 - 329.83|
|PE Ratio (TTM)||17.73|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Late last week, Biogen (BIIB) and six other pharma and biotech stocks were in the news due to the pricing of their multiple sclerosis ("MS") drugs.
Biogen is taking a political risk with aggressive multiple sclerosis drug pricing, but the company is under pressure to boost its share price.